Pathopharm Exam 2-S4 Flashcards
This receptor affects the arteries more than veins.
-Increases vascular tone by vasoconstriction to increase Blood pressure?
Alpha-1 receptor
This receptor is found primarily on heart and increases heart rate and contractility.
-Also increases risk of arrhythmias?
Beta-1 receptor
This receptor is found in arteries and veins and inhibits adenyl cyclase to decrease norepinephrine release and increase parasympathetic outflow?
Alpha-2 receptor
This receptor causes smooth muscle relaxation and should be avoided with asthmatic patients?
Beta-2 receptor
This drug is an alpha-1 and alpha-2 agonist.
- Endogenous catecholamine.
- Arterial and Venous constriction
- Increase BP, SVR and PVR
- may slow HR due to baroreceptor mechanism
- Does not increase myocardial O2 consumption
- Dose not cross BBB
Norepinephrine (Levophed)
This drug is an alpha-1 agonist
- Causes vasoconstriction, bradycardia
- Coronary vasoconstrictor
- Increase BP, SVR, PVR, and afterload.
- May need to add dopamine to keep HR up.
- Often used in neurologic shock
- Contraindicated w narrow angle glaucoma
Neosynephrine (Phenylephrine)
This drug is a beta-1 agonist
- Synthetic catecholamine
- reduced preload and afterload
- increases contractility, CO, HR and BP.
- Also increases myocardial O2 demand.
- May drop BP if patient is dehydrated.
Dobutamine
This drug is a beta-1 and alpha-1 agonist and works at DA receptors
- First line agent for shock
- Naturally occurring catecholamine
- Precursor to norepi
- Dilates/increases renal blood flow
Dopamine
Low dose Dopamine affects what?
1-3 mcg/kg/min
Renal, coronary and cerebral vasodilation. Increased urinary output
Mid dose Dopamine affects what?
3-10 mcg/kg/min
Beta-1 stimulation with positive ionotropic effect.
Increased HR and small BP increase
High dose Dopamine affects what?
>10 mcg/kg/min
Alpha-1 stimulation with potent vasoconstriction.
Increased BP and increased SVR
This drug is a beta-1 and alpha-1 agonist
- Endogenous catecholamine
- causes peripheral and global vasoconstriction
- Bronchodilation
- NOT first line treatment
- Increases cardiac contractility and O2 demand.
- Increased HR, MAP, CO, SVR, PVR
- Risk of arrhythmia development
- Systolic increase and diastolic decrease
- Does not cross BBB
Epinephrine
This drug is a VP-1 agonist
- ADH
- causes smooth muscle constriction
- Used in ACLS for pulseless VT and VF
- Less constriction at coronary and renal beds
- Vasodilates cerebral vasculature
- May enhance platelet aggregration in septic shock
- Increases BP, MAP, SVR, and UO
Vasopressin
This drug is a vasopressin analog, agonist at VP-1
- IV only
- Control of Low BP
- Used for patients who do not respond to Norepi
- Useful to treat bleeding esophageal varices
- avoid use in hypoxic patients
Terlipressin
This drug is a PDE-3 inhibitor
- Positive inotrope and vasodilator
- Cleared by liver, can accumulate with liver dz
- Increases cAMP causing increased Ca into cells to improve myocardial contractility and inhibit vasoconstriction.
- Increases CO
- Decreases CVP, SVR
Milrinone
This drug is indicated for severely low BP in septic or distributive shock
- very short half life (1 min)
- IV infusion only
- titrate BP to proper range
- May cause clots and DVTs
- Must be given with anti-clotting therapeutics
Angiotensin II acetate (Giapreza)
This drug is a Na/K ATPase inhibitor
- narrow therapeutic window
Used in systolic heart failure with decreased CO
- Used with atrial fib and SVT
- Increases Cardiac output
- Increases voltage at rest.
- Used more in outpatient PO
Digoxin
NE > EPI > DA > ISO
Alpha-1 agonist potency
EPI > NE > DA > ISO
Alpha-2 agonist potency
ISO > EPI = NE > DA
Beta-1 agonist potency
ISO > EPI > NE > DA
Beta- 2 agonist potency
ISO = NE > EPI > DA
Beta-3 agonist potency
Muscarinic receptor structure/function?
G-protein
Nicotinic receptor structure/function?
Ionophore